This is the current revision of this page, as edited by Hasley(discuss | contribs) at 21:38, 2 November 2019. The present address (URL) is a permanent link to this version.
Phase III Randomized Comparison of ADR/5-FU plus I131-Antiferritin IgG vs ADR/5-FU Alone Following ADR/5-FU plus External Beam Radiotherapy in Nonmetastatic Nonresectable Primary Hepatoma